Genetic regulation of pristane-induced oil granuloma responses

International Journal of Experimental Pathology

Volumn 91, Issue 5, 2010, Pages 472-483

  Chen, Huaiyong ^a   Liao, Dongmei ^a   Matt Holl, T ^a   Snowden, Pilar ^a   Ueda, Yoshihiro ^a   Kelsoe, Garnett ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B cells; Non infectious granuloma; Pristane; Tertiary lymphoid tissue; TNF

Indexed keywords

INTERLEUKIN 6; LYMPHOTOXIN; PRISTANE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; DRUG INDUCED DISEASE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC REGULATION; GRANULOMA; LYMPHOCYTE COUNT; MALE; MESENTERY TUMOR; MOUSE; NONHUMAN; OIL GRANULOMA; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; B-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION; GRANULOMA; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; LYMPHOID TISSUE; LYMPHOTOXIN-ALPHA; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PHOSPHOPROTEINS; TERPENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78449279187     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2010.00732.x     Document Type: Article

References (43)

1. Aggarwal B.B., Shishodia S., Ashikawa K., Bharti A.C. (2002) The role of TNF and its family members in inflammation and cancer: lessons from gene deletion. Curr. Drug Targets Inflamm. Allergy 1, 327-341.
2. Aloisi F. & Pujol-Borrell R. (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6, 205-217.
3. Bistrup A., Tsay D., Shenoy P. et al. (2004) Detection of a sulfotransferase (HEC-GlcNAc6ST) in high endothelial venules of lymph nodes and in high endothelial venule-like vessels within ectopic lymphoid aggregates: relationship to the MECA-79 epitope. Am. J. Pathol. 164, 1635-1644.
4. Bowdish D.M., Sakamoto K., Kim M. et al. (2009) MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PloS Pathol. 5, e1000474.
5. Chaplin D.D. & Fu Y. (1998) Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 10, 289-297.
6. Chen S.C., Vassileva G., Kinsley D. et al. (2002) Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168, 1001-1008.
7. Chen H., Liao D., Cain D. et al. (2010) Distinct granuloma responses in C57BL/6J and BALB/cByJ mice in response to pristane. Int. J. Exp. Pathol. 91, 460-471.
8. Co D.O., Hogan L.H., Kim S.I., Sandor M. (2004) Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship Clin. Immunol. 113, 130-136.
9. De Togni P., Goellner J., Ruddle N.H. et al. (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264, 703-707.
10. Douglas M.R., Morrison K.E., Salmon M., Buckley C.D. (2002) Why does inflammation persist: a dominant role for the stromal microenvironment? Expert Rev. Mol. Med. 4, 1-18.
11. Drayton D.L., Liao S., Mounzer R.H., Ruddle N.H. (2006) Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7, 344-353.
12. Duijvestijn A.M., Horst E., Pals S.T. et al. (1988) High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am. J. Pathol. 130, 147-155.
13. Epstein E. (1955) Silica granuloma of the skin. AMA Arch. Derm. 71, 24-35.
14. Fu Y.X., Molina H., Matsumoto M., Huang G., Min J., Chaplin D.D. (1997) Lymphotoxin-alpha (LTα ) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185, 2111-2120.
15. Gabay C. (2006) Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8(Suppl 2), S3.
16. Griffiths M.M., Langone J.J., Lightfoote M.M. (1996) Biomaterials and granulomas. Methods 9, 295-304.
17. Hinze C.H. & Colbert R.A. (2008) B-cell depletion in Wegener's granulomatosis. Clin. Rev. Allergy Immunol. 34, 372-379.
18. Hjelmstrom P. (2001) Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol. 69, 331-339.
19. Hornung V., Bauernfeind F., Halle A. et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847-856.
20. Kawamura T., Kanai T., Dohi T. et al. (2004) Ectopic CD40 ligand expression on B cells triggers intestinal inflammation. J. Immunol. 172, 6388-6397.
21. Kim Y.K. & Park H.S. (2008) Foreign body granuloma of activated charcoal. Abdom. Imaging 33, 94-97.
22. Kishimoto T. (2005) Interleukin-6: from basic science to medicine - 40 years in immunology. Annu. Rev. Immunol. 23, 1-21.
23. Kitamura D. (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423-426.
24. Kopf M, Baumann H., Freer G. et al. (1994) Impaired immune and acute-phase responses in interliukin-6-deficient mice. Nature 368, 339-342.
25. Kratz A., Campos-Neto A., Hanson M.S., Ruddle N.H. (1996) Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183, 1461-1472.
26. Luther S.A., Bidgol A., Hargreaves D.C. et al. (2002) Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169, 424-433.
27. Maglione P.J., Xu J., Chan J. (2007) B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J. Immunol. 178, 7222-7234.
28. Marino M.W., Dunn A., Grail D. et al. (1997) Characterization of tumor necrosis factor-deficient mice. Proc. Natl Acad. Sci. USA 94, 8093-8098.
29. Nacionales D.C., Kelly K.M., Lee P.Y. et al. (2006) Type I interferon production by tertiary lymphoid tissue developing in response to 2, 6, 10, 14-tetramethyl-pentadecane (pristane). Am. J. Pathol. 168, 1227-1240.
30. Nacionales D.C., Kelly-Scumpia K.M., Lee P.Y. et al. (2007) Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum. 56, 3770-3783.
31. Nicolau P.J. (2007) Long-lasting and permanent fillers: biomaterial influence over host tissue response. Plast. Reconstr. Surg. 119, 2271-2286.
32. Pasparakis M. (1996) Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397-1411.
33. Potter M. & Maccardle R.C. (1964) Histology of developing plasma cell neoplasia induced by mineral oil In BALB/C Mice. J. Natl Cancer Inst. 33, 497-515.
34. Ruddle N.H. (1999) Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development. Immunol. Res. 19, 119-125.
35. Sabatini F., Silvestri M., Sale R. et al. (2002) Fibroblast-eosinophil interaction: modulation of adhesion molecules expression and chemokine release by human fetal lung fibroblasts in response to IL-4 and TNF-alpha. Immunol. Lett. 84, 173-178.
36. Savarese E., Steinberg C., Pawar R.D. et al. (2008) Requirement of toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum. 58, 1107-1115.
37. Schroder A.E., Greiner A., Seyfert C., Berek C. (1996) Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl Acad. Sci. USA 93, 221-225.
38. Tang L. & Eaton J.W. (1995) Inflammatory responses to biomaterials. Am. J. Clin. Pathol. 103, 466-471.
39. Thibault D.L., Chu A.D., Graham K.L. et al. (2008) IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J. Clin. Invest. 118, 1417-1426.
40. Welsh K.J., Abbott A.N., Hwang S.A. et al. (2008) A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6, 6'-dimycolate induced granulomatous response. Microbiology 154, 1813-1824.
41. Young C.L., Adamson T.C., III, Vaughan J.H., Fox R.I. (1984) Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum. 27, 32-39.
42. Zeller J.M. (1983) Surgical implants. Physiological response. AORN J. 37, 1284-1291.
43. Zhang W., Sommers C.L., Burshtyn D.N. et al. (1999) Essential role of LAT in T cell development. Immunity 10, 323-332.